Investor Mukul Agarwal has added two new stocks to his portfolio, now valued at over Rs 6,615 crore. One acquisition is Hindustan Construction Company (HCC), a long-standing infrastructure firm where Agarwal purchased a 1.7% stake worth Rs 80 crore. The other pick is a recently listed pharmaceutical company, noted for its strong financial efficiency, contrasting with HCC's profit performance. These contrasting investments have generated significant interest and speculation within investor circles regarding Agarwal's strategy.